Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 146,750 | 110,510 | 83,630 | 33,120 | 24,500 |
| Cost of Goods | 24,320 | 19,070 | 14,930 | 6,940 | 0 |
| Gross Profit | 122,420 | 91,440 | 68,690 | 26,170 | 24,500 |
| Operating Expenses | 65,180 | 61,530 | 42,450 | 48,380 | 47,260 |
| Operating Income | 57,570 | 29,980 | 27,180 | -21,260 | -22,760 |
| Interest Expense | 2,350 | 0 | 900 | 500 | 0 |
| Other Income | 13,550 | -4,990 | 19,740 | 28,120 | 0 |
| Pre-tax Income | 68,770 | 24,990 | 46,020 | 6,360 | -22,760 |
| Income Tax | 23,950 | 11,390 | -32,820 | 0 | 0 |
| Net Income Continuous | 44,561 | 20,603 | 25,515 | 6,159 | -22,768 |
| Net Income | $44,810 | $13,590 | $78,840 | $6,360 | $-22,760 |
| EPS Basic Total Ops | 3.25 | 0.90 | 5.80 | 0.45 | -1.85 |
| EPS Basic Continuous Ops | 3.24 | 1.51 | 1.88 | 0.46 | -1.85 |
| EPS Diluted Total Ops | 3.25 | 0.90 | 5.75 | 0.45 | -1.85 |
| EPS Diluted Continuous Ops | 3.23 | 1.51 | 1.88 | 0.46 | -1.85 |
| EBITDA(a) | $61,100 | $33,100 | $30,720 | $-19,160 | $-21,870 |